{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:45:08Z","timestamp":1784295908583,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["U01AG029824"],"award-info":[{"award-number":["U01AG029824"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["U19AG062682"],"award-info":[{"award-number":["U19AG062682"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["334047"],"award-info":[{"award-number":["334047"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1127060"],"award-info":[{"award-number":["1127060"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1135727"],"award-info":[{"award-number":["1135727"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1RF1AG079397"],"award-info":[{"award-number":["1RF1AG079397"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01985-z","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:44:18Z","timestamp":1764269058000},"page":"2001-2012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma biomarkers of alzheimer\u2019s disease and related dementias are associated with cognitive change in community-dwelling older individuals in Australia and the US"],"prefix":"10.1007","volume":"48","author":[{"given":"Zimu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor T.-J.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry M.","family":"Sheets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"12","key":"1985_CR1","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, et al. The Alzheimer\u2019s association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 2022;18(12):2669\u201386.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1985_CR2","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1136\/jnnp-2014-307662","volume":"85","author":"RM Ahmed","year":"2014","unstructured":"Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O\u2019Brien JT, Fox NC, et al. Biomarkers in dementia: clinical utility and new directions. J Neurol Neurosurg Psychiatry. 2014;85(12):1426\u201334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1985_CR3","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1212\/WNL.0000000000201479","volume":"100","author":"V Planche","year":"2023","unstructured":"Planche V, Bouteloup V, Pellegrin I, Mangin JF, Dubois B, Ousset PJ, et al. Validity and performance of blood biomarkers for Alzheimer disease to predict dementia risk in a large clinic-based cohort. Neurology. 2023;100(5):e473\u201384.","journal-title":"Neurology"},{"issue":"15","key":"1985_CR4","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/jama.2024.6619","volume":"332","author":"Y Lu","year":"2024","unstructured":"Lu Y, Pike JR, Chen J, Walker KA, Sullivan KJ, Thyagarajan B, et al. Changes in Alzheimer disease blood biomarkers and associations with incident all-cause dementia. JAMA. 2024;332(15):1258\u201369.","journal-title":"JAMA"},{"issue":"4","key":"1985_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","volume":"80","author":"N Mattsson-Carlgren","year":"2023","unstructured":"Mattsson-Carlgren N, Salvado G, Ashton NJ, Tideman P, Stomrud E, Zetterberg H, et al. Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers. JAMA Neurol. 2023;80(4):360\u20139.","journal-title":"JAMA Neurol"},{"issue":"6","key":"1985_CR6","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1002\/alz.13829","volume":"20","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ferreira PCL, Jacobsen E, Bellaver B, Pascoal TA, Snitz BE, et al. Association of plasma biomarkers of Alzheimer\u2019s disease and related disorders with cognition and cognitive decline: The MYHAT population-based study. Alzheimers Dement. 2024;20(6):4199\u2013211.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1985_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D\u2019Anna L, Huss A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"1985_CR8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1985_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ana.26308","volume":"91","author":"PF Meyer","year":"2022","unstructured":"Meyer PF, Ashton NJ, Karikari TK, Strikwerda-Brown C, Kobe T, Gonneaud J, et al. Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults. Ann Neurol. 2022;91(4):548\u201360.","journal-title":"Ann Neurol"},{"issue":"8","key":"1985_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41582-024-00989-1","volume":"20","author":"MM Mielke","year":"2024","unstructured":"Mielke MM, Fowler NR. Alzheimer disease blood biomarkers: considerations for population-level use. Nat Rev Neurol. 2024;20(8):495\u2013504.","journal-title":"Nat Rev Neurol"},{"key":"1985_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107231","volume":"130","author":"ME Ernst","year":"2023","unstructured":"Ernst ME, Broder JC, Wolfe R, Woods RL, Nelson MR, Ryan J, et al. Health characteristics and aspirin use in participants at the baseline of the ASPirin in reducing events in the elderly - eXTension (ASPREE-XT) observational study. Contemp Clin Trials. 2023;130:107231.","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"1985_CR12","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/gerona\/glw342","volume":"72","author":"JJ McNeil","year":"2017","unstructured":"McNeil JJ, Woods RL, Nelson MR, Murray AM, Reid CM, Kirpach B, et al. Baseline characteristics of participants in the ASPREE (aspirin in reducing events in the elderly) study. J Gerontol A Biol Sci Med Sci. 2017;72(11):1586\u201393.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1985_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294743","volume":"19","author":"EJ Parker","year":"2024","unstructured":"Parker EJ, Orchard SG, Gilbert TJ, Phung JJ, Owen AJ, Lockett T, et al. The ASPREE healthy ageing biobank: methodology and participant characteristics. PLoS ONE. 2024;19(2):e0294743.","journal-title":"PLoS ONE"},{"issue":"4","key":"1985_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100058","volume":"12","author":"Z Wu","year":"2025","unstructured":"Wu Z, Mielke MM, Murray AM, Phung J, Owen A, Woods RL, et al. The impact of pre-analytical factors on plasma biomarkers for Alzheimer\u2019s disease: the ASPREE Healthy Ageing Biobank. J Prev Alzheimers Dis. 2025;12(4):100058.","journal-title":"J Prev Alzheimers Dis"},{"key":"1985_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100058","author":"Z Wu","year":"2025","unstructured":"Wu Z, Mielke MM, Murray AM, Phung J, Owen A, Woods RL, et al. The impact of pre-analytical factors on plasma biomarkers for Alzheimer\u2019s disease: the ASPREE Healthy Ageing Biobank. J Prev Alzheimers Dis. 2025. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100058.","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"1985_CR16","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1212\/WNL.0000000000009277","volume":"95","author":"J Ryan","year":"2020","unstructured":"Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, et al. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology. 2020;95(3):e320\u201331.","journal-title":"Neurology"},{"issue":"1","key":"1985_CR17","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41467-021-23746-0","volume":"12","author":"NC Cullen","year":"2021","unstructured":"Cullen NC, Leuzy A, Janelidze S, Palmqvist S, Svenningsson AL, Stomrud E, et al. Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat Commun. 2021;12(1):3555.","journal-title":"Nat Commun"},{"issue":"4","key":"1985_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cger.2013.07.002","volume":"29","author":"CN Harada","year":"2013","unstructured":"Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clin Geriatr Med. 2013;29(4):737\u201352.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"1985_CR19","first-page":"e12180","volume":"13","author":"Z Wu","year":"2021","unstructured":"Wu Z, Woods RL, Wolfe R, Storey E, Chong TTJ, Shah RC, et al. Trajectories of cognitive function in community-dwelling older adults: a longitudinal study of population heterogeneity. Alzheimer\u2019s Dementia: Diagnosis, Assess Dis Monit. 2021;13(1):e12180.","journal-title":"Alzheimer's Dementia: Diagnosis, Assess Dis Monit"},{"issue":"1","key":"1985_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3233\/ADR-230089","volume":"7","author":"A Zhou","year":"2023","unstructured":"Zhou A, Britt C, Woods RL, Orchard SG, Murray AM, Shah RC, et al. Normative Data for Single-Letter Controlled Oral Word Association Test in Older White Australians and Americans, African-Americans, and Hispanic\/Latinos. J Alzheimers Dis Rep. 2023;7(1):1033\u201343.","journal-title":"J Alzheimers Dis Rep"},{"issue":"4","key":"1985_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.0000000000207193","volume":"101","author":"D Alcolea","year":"2023","unstructured":"Alcolea D, Beeri MS, Rojas JC, Gardner RC, Lleo A. Blood biomarkers in neurodegenerative diseases: implications for the clinical neurologist. Neurology. 2023;101(4):172\u201380.","journal-title":"Neurology"},{"key":"1985_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200052","author":"C Barro","year":"2023","unstructured":"Barro C, Healy BC, Liu Y, Saxena S, Paul A, Polgar-Turcsanyi M, et al. Serum GFAP and NfL levels differentiate subsequent progression and disease activity in patients with progressive multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023. https:\/\/doi.org\/10.1212\/NXI.0000000000200052.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1985_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03418-8","author":"X Wang","year":"2024","unstructured":"Wang X, Shi Z, Qiu Y, Sun D, Zhou H. Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank. BMC Med. 2024. https:\/\/doi.org\/10.1186\/s12916-024-03418-8.","journal-title":"BMC Med"},{"key":"1985_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091309","author":"KY Kim","year":"2023","unstructured":"Kim KY, Shin KY, Chang KA. GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12091309.","journal-title":"Cells"},{"issue":"4","key":"1985_CR25","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Dore V, et al. Plasma Abeta42\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2023;19(4):1117\u201334.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1985_CR26","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/alz.13560","volume":"20","author":"E Sanchez","year":"2024","unstructured":"Sanchez E, Wilkinson T, Coughlan G, Mirza S, Baril AA, Ramirez J, et al. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: results from the Ontario Neurodegenerative Disease Research Initiative. Alzheimers Dement. 2024;20(3):1753\u201370.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"1985_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-014-0082-1","volume":"6","author":"J Rahimi","year":"2014","unstructured":"Rahimi J, Kovacs GG. Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther. 2014;6(9):82.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1985_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1373\/jalm.2019.030023","volume":"5","author":"MM Mielke","year":"2020","unstructured":"Mielke MM. Consideration of Sex Differences in the Measurement and Interpretation of Alzheimer Disease-Related Biofluid-Based Biomarkers. J Appl Lab Med. 2020;5(1):158\u201369.","journal-title":"J Appl Lab Med"},{"issue":"10","key":"1985_CR29","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1038\/s41380-022-01675-8","volume":"27","author":"AA Tsiknia","year":"2022","unstructured":"Tsiknia AA, Edland SD, Sundermann EE, Reas ET, Brewer JB, Galasko D, et al. Sex differences in plasma p-tau181 associations with Alzheimer\u2019s disease biomarkers, cognitive decline, and clinical progression. Mol Psychiatry. 2022;27(10):4314\u201322.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1985_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12369","volume":"14","author":"C Liu","year":"2022","unstructured":"Liu C, Li Y, Nwosu A, Ang TFA, Liu Y, Devine S, et al. Sex-specific biomarkers in Alzheimer\u2019s disease progression: Framingham Heart Study. Alzheimer\u2019s & Demen: Diagnos, Assess Dis Monit. 2022;14(1):e12369.","journal-title":"Alzheimer's & Demen: Diagnos, Assess Dis Monit"},{"issue":"10","key":"1985_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt9243","volume":"11","author":"AK Bonkhoff","year":"2025","unstructured":"Bonkhoff AK, Coughlan G, Perosa V, Alhadid K, Schirmer MD, Regenhardt RW, et al. Sex differences in age-associated neurological diseases-a roadmap for reliable and high-yield research. Sci Adv. 2025;11(10):eadt9243.","journal-title":"Sci Adv"},{"issue":"8","key":"1985_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, et al. Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 2018;14(8):989\u201397.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1985_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2019.05.017","volume":"74","author":"DA Drew","year":"2019","unstructured":"Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74(6):782\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1985_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66\u201377.","journal-title":"Lancet Neurol"},{"key":"1985_CR35","unstructured":"A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD) (SKYLINE). 2024"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01985-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01985-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01985-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:41:35Z","timestamp":1773049295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01985-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01985-z","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anne M. Murray reports grants from the National Institute of Health. Michelle M. Mielke reports grants from the National Institute of\u00a0Health, DOD, Alzheimer's Association and Davos Alzheimer's Collaborative, payments from Athira, Biogen, Eisai, Lilly, Merck, Roche,\u00a0Siemens Healthineers, Novo Nordisk and Alzheimer's Drug Discovery Foundation. Trevor T.-J. Chong reports honoraria for lectures\u00a0from Roche. Kerry M. Sheets reports grants from the American Association of Retired Persons and Optum Labs, National Institute on\u00a0Aging, and Agency for Healthcare Research and Quality, as well as honoraria from the International Antiviral Society USA. Joanne\u00a0Ryan reports funding from the National Institute of Health, the National Health and Medical Research Council, the Medical Research\u00a0Future Fund and the Australian Research Council, honoraria from the Victorian Coronial Council\u2013Department of Justice and\u00a0Community Service, and serving as a non-paid committee member and a scientific board member for Dementia Australia. Zimu Wu,\u00a0Katherine Webb, Robyn L. Woods, Alice Owen and Suzanne G. Orchard report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}